New York Times
NYT
64.90
+1.06
+1.66%
New York Times
US · NYT
#1455 by market cap
Listed 1978
64.90
+1.06
+1.66%
Live - 5344 symbols - heartbeat 138s ago
· 2026-10-08 07:26
Pre-market
65.00
+0.15%
After-hours
64.74
-0.25%
Overnight
64.43
-0.72%
- Market cap
- 10.47B
- P/E (TTM)i
- 27.04
- P/Bi
- 5.11
- EPSi
- 2.09
- Div yieldi
- 1.19%
- 52W posi
- 35%
Reader sentiment
Are you bullish or bearish on NYT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 9.35, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.24% YoY
Margins
- Gross margin
- 50.81%
- Operating margin
- 15.95%
- Net margin
- 12.18%
Key ratios & quality
- PEG ratioi
- 1.06
- Altman Z-Scorei
- 9.35
PEG uses trailing P/E against the 3-year net income growth rate (25.53%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.75B | 1.81B | 1.78B | 2.07B | 2.31B | 2.43B | 2.59B | 2.82B |
| Gross profit | 800.71M | 824.03M | 824.33M | 1.04B | 1.10B | 1.18B | 1.28B | 1.44B |
| Selling & admin expenses | 472.29M | 479.40M | 452.55M | 545.07M | 556.81M | 571.27M | 586.36M | 635.15M |
| Research & development | 84.10M | 106.42M | 133.38M | 160.87M | 204.19M | 228.80M | 248.20M | 264.35M |
| Operating profit | 185.32M | 177.55M | 176.26M | 271.87M | 255.74M | 290.91M | 358.92M | 450.70M |
| Pretax profit | 176.09M | 164.46M | 115.43M | 290.50M | 236.00M | 302.59M | 383.42M | 451.26M |
| Tax | 48.63M | 24.49M | 14.60M | 70.53M | 62.09M | 69.84M | 89.60M | 107.28M |
| Net profit | 127.46M | 139.97M | 100.84M | 219.97M | 173.91M | 232.75M | 293.83M | 343.98M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Diluted EPS | 0.75 | 0.83 | 0.60 | 1.31 | 1.04 | 1.40 | 1.77 | 2.09 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 635.91M | 685.87M | 700.82M | 802.31M | 712.24M | 762.46M |
| Gross profit | 301.27M | 347.09M | 351.75M | 435.09M | 349.30M | 394.61M |
| Selling & admin expenses | 145.87M | 151.72M | 156.22M | 181.34M | 163.72M | 180.50M |
| Research & development | 66.54M | 63.94M | 66.99M | 66.88M | 70.19M | 70.35M |
| Operating profit | 67.48M | 110.04M | 107.20M | 165.98M | 94.83M | 122.65M |
| Pretax profit | 63.97M | 111.66M | 108.00M | 167.63M | 98.32M | 125.22M |
| Tax | 14.42M | 28.72M | 26.35M | 37.79M | 10.40M | 31.80M |
| Net profit | 49.55M | 82.95M | 81.65M | 129.84M | 87.92M | 93.42M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.30 | 0.50 | 0.50 | 0.79 | 0.54 | 0.57 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 893.95M | 716.83M | 835.84M | 952.71M | 655.68M | 781.65M | 936.32M | 1.03B |
| Cash & ST investments | 612.81M | 432.22M | 595.16M | 661.05M | 347.36M | 451.57M | 565.92M | 642.16M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 2.20B | 2.09B | 2.31B | 2.56B | 2.53B | 2.71B | 2.84B | 3.00B |
| Total current liabilities | 673.30M | 437.70M | 486.75M | 559.15M | 571.21M | 611.56M | 613.53M | 666.70M |
| Short-term debt | 253.63M | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,154,482,000.00 | 915,275,000.00 | 979,578,000.00 | 1,023,383,000.00 | 933,780,000.00 | 951,376,000.00 | 914,270,000.00 | 955,727,000.00 |
| Total equity | 1.04B | 1.17B | 1.33B | 1.54B | 1.60B | 1.76B | 1.93B | 2.04B |
| Retained earnings | 1.51B | 1.61B | 1.67B | 1.85B | 1.96B | 2.12B | 2.33B | 2.55B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 801.57M | 855.00M | 938.30M | 1.03B | 927.21M | 1.02B |
| Cash & ST investments | 522.07M | 540.25M | 617.35M | 642.16M | 594.52M | 660.81M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.74B | 2.81B | 2.89B | 3.00B | 2.86B | 2.98B |
| Total current liabilities | 554.85M | 577.99M | 615.49M | 666.70M | 577.88M | 647.72M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 850,209,000.00 | 869,328,000.00 | 906,874,000.00 | 955,727,000.00 | 857,870,000.00 | 936,994,000.00 |
| Total equity | 1.88B | 1.94B | 1.98B | 2.04B | 2.00B | 2.05B |
| Retained earnings | 2.35B | 2.40B | 2.45B | 2.55B | 2.60B | 2.66B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 157.12M | 189.90M | 297.93M | 269.10M | 150.69M | 360.62M | 410.51M | 584.49M |
| Depreciation & amortization | 59.01M | 68.05M | 70.70M | 66.99M | 92.58M | 95.35M | 92.02M | 95.15M |
| Free cash flow | 79.63M | 144.46M | 263.48M | 234.46M | 113.73M | 337.95M | 381.34M | 550.51M |
| Dividends paid | -26.42M | -31.60M | -38.44M | -45.34M | -56.79M | -69.46M | -82.86M | -110.36M |
| Stock buybacks / issuance | 41.29M | 4.52M | 6.07M | 2.45M | -105.05M | -44.55M | -85.04M | -165.34M |
| Ending cash balance | 259.80M | 247.52M | 301.96M | 334.31M | 235.17M | 303.17M | 213.86M | 270.46M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 99.09M | 113.64M | 207.61M | 164.16M | 92.24M | 194.26M |
| Depreciation & amortization | 23.71M | 23.73M | 23.87M | 23.85M | 23.33M | 23.77M |
| Free cash flow | 89.85M | 103.30M | 199.73M | 157.62M | 81.51M | 184.15M |
| Dividends paid | -22.07M | -29.60M | -29.40M | -29.29M | -30.39M | -37.19M |
| Stock buybacks / issuance | -58.96M | -23.60M | -27.32M | -55.46M | -56.35M | -35.43M |
| Ending cash balance | 197.16M | 212.96M | 264.21M | 270.46M | 200.47M | 246.52M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.97 | 12.65 | 8.02 | 15.36 | 11.09 | 13.83 | 15.92 | 17.34 |
| ROA %i | 5.85 | 6.53 | 4.55 | 9.03 | 6.82 | 8.86 | 10.58 | 11.78 |
| ROIC %i | 11.06 | 12.44 | 6.12 | 14.47 | 10.38 | 12.48 | 14.10 | 15.42 |
| 5-year avg ROE %i | 5.86 | 7.55 | 7.52 | 9.90 | 12.02 | 12.19 | 12.84 | 14.71 |
| EBIT margin %i | 11.65 | 10.56 | 6.51 | 14.04 | 10.26 | 12.51 | 14.87 | 16.02 |
| FCF / sales %i | 4.55 | 7.97 | 14.77 | 11.30 | 4.93 | 13.93 | 14.75 | 19.49 |
| Current ratioi | 1.33 | 1.64 | 1.72 | 1.70 | 1.15 | 1.28 | 1.53 | 1.54 |
| Quick ratioi | 1.24 | 1.48 | 1.60 | 1.60 | 0.99 | 1.13 | 1.33 | 1.40 |
| Debt / assetsi | 11.54 | 2.64 | 2.28 | 2.48 | 2.33 | 1.58 | 1.31 | 1.22 |
| LT debt / equityi | -- | 4.70 | 3.98 | 4.13 | 3.70 | 2.43 | 1.93 | 1.79 |
| Interest coveragei | 7.36 | 7.12 | 159.78 | 378.76 | 297.11 | 299.41 | 378.01 | 387.68 |
| Revenue CAGR (3Y) %i | 3.45 | 5.23 | 2.10 | 5.87 | 8.40 | 10.80 | 7.62 | 6.96 |
| Net income CAGR (3Y) %i | 25.72 | 68.86 | 185.62 | 20.51 | 7.51 | 32.41 | 10.13 | 25.53 |
| FCF CAGR (3Y) %i | -19.41 | 25.10 | 412.36 | 43.33 | -7.66 | 8.65 | 17.60 | 69.16 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 16.68 | 17.13 | 17.63 | 17.34 | 19.68 | 19.72 |
| ROA %i | 11.31 | 11.70 | 11.96 | 11.78 | 13.67 | 13.57 |
| ROIC %i | 15.06 | 15.52 | 15.98 | 15.42 | 17.86 | 17.91 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.95 | 15.53 | 16.02 | 16.02 | 16.54 | 16.68 |
| FCF / sales %i | 16.16 | 16.93 | 19.52 | 19.49 | 18.69 | 20.92 |
| Current ratioi | 1.44 | 1.48 | 1.52 | 1.54 | 1.60 | 1.58 |
| Quick ratioi | 1.29 | 1.30 | 1.33 | 1.40 | 1.44 | 1.38 |
| Debt / assetsi | -- | -- | -- | 1.22 | -- | -- |
| LT debt / equityi | -- | -- | -- | 1.79 | -- | -- |
| Interest coveragei | 387.33 | 377.76 | 389.39 | 387.68 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 07:26:24 · For reference only, not investment advice and not tailored to your situation.